These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


695 related items for PubMed ID: 19572413

  • 1. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
    Tu S, Wai-Yin Sun R, Lin MC, Tao Cui J, Zou B, Gu Q, Kung HF, Che CM, Wong BC.
    Cancer; 2009 Oct 01; 115(19):4459-69. PubMed ID: 19572413
    [Abstract] [Full Text] [Related]

  • 2. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
    Wang Y, He QY, Sun RW, Che CM, Chiu JF.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):113-22. PubMed ID: 17116302
    [Abstract] [Full Text] [Related]

  • 3. Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo.
    Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, Tsubura A.
    Anticancer Res; 2005 Jan 12; 25(3B):2269-76. PubMed ID: 16158974
    [Abstract] [Full Text] [Related]

  • 4. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW, Li CK, Ma DL, Yan JJ, Lok CN, Leung CH, Zhu N, Che CM.
    Chemistry; 2010 Mar 08; 16(10):3097-113. PubMed ID: 20162647
    [Abstract] [Full Text] [Related]

  • 5. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.
    Cancer Chemother Pharmacol; 2009 Dec 08; 65(1):13-25. PubMed ID: 19387645
    [Abstract] [Full Text] [Related]

  • 6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 08; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 7. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB, Zhou JH, Zuo MX, You QD.
    Yao Xue Xue Bao; 2008 Aug 08; 43(8):811-8. PubMed ID: 18956773
    [Abstract] [Full Text] [Related]

  • 8. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC.
    J Gastroenterol Hepatol; 2008 Jul 08; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [Abstract] [Full Text] [Related]

  • 9. Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro.
    Lum CT, Liu X, Sun RW, Li XP, Peng Y, He ML, Kung HF, Che CM, Lin MC.
    Cancer Lett; 2010 Aug 28; 294(2):159-66. PubMed ID: 20163914
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest.
    Wu CH, Jeng JH, Wang YJ, Tseng CJ, Liang YC, Chen CH, Lee HM, Lin JK, Lin CH, Lin SY, Li CP, Ho YS.
    Toxicol Appl Pharmacol; 2002 Apr 01; 180(1):22-35. PubMed ID: 11922774
    [Abstract] [Full Text] [Related]

  • 11. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft.
    Tin MM, Cho CH, Chan K, James AE, Ko JK.
    Carcinogenesis; 2007 Jun 01; 28(6):1347-55. PubMed ID: 17148504
    [Abstract] [Full Text] [Related]

  • 12. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways.
    Wang Y, He QY, Che CM, Tsao SW, Sun RW, Chiu JF.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1282-91. PubMed ID: 18241839
    [Abstract] [Full Text] [Related]

  • 13. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
    Saleem M, Maddodi N, Abu Zaid M, Khan N, bin Hafeez B, Asim M, Suh Y, Yun JM, Setaluri V, Mukhtar H.
    Clin Cancer Res; 2008 Apr 01; 14(7):2119-27. PubMed ID: 18381953
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells.
    Min HY, Chung HJ, Kim EH, Kim S, Park EJ, Lee SK.
    Biochem Pharmacol; 2010 Nov 01; 80(9):1356-64. PubMed ID: 20674553
    [Abstract] [Full Text] [Related]

  • 15. Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.
    Lum CT, Huo L, Sun RW, Li M, Kung HF, Che CM, Lin MC.
    Acta Oncol; 2011 Jun 01; 50(5):719-26. PubMed ID: 21110776
    [Abstract] [Full Text] [Related]

  • 16. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM, Qian DZ, Carducci MA, Pili R.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):329-39. PubMed ID: 17256134
    [Abstract] [Full Text] [Related]

  • 17. Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug.
    Wang Y, He QY, Che CM, Chiu JF.
    Proteomics; 2006 Jan 01; 6(1):131-42. PubMed ID: 16287165
    [Abstract] [Full Text] [Related]

  • 18. Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo.
    Tao L, Zhou L, Zheng L, Yao M.
    Cancer Chemother Pharmacol; 2006 Jul 01; 58(1):24-34. PubMed ID: 16283311
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL.
    Cancer Chemother Pharmacol; 2005 May 01; 55(5):425-32. PubMed ID: 15565325
    [Abstract] [Full Text] [Related]

  • 20. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ.
    Clin Cancer Res; 2005 May 01; 11(9):3475-84. PubMed ID: 15867250
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.